GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

etesevimab   Click here for help

GtoPdb Ligand ID: 11331

Synonyms: CB-6 | JS-016 | LY-CoV016 | LY3832479
Compound class: Antibody
Comment: Etesevimab (LY3832479) is a monoclonal antibody against the surface spike protein of SARS-CoV-2. It was developed by Eli Lilly, but such is the speed of COVID-19 therapeutic development, there are no peer-reviewed articles that report its design, preclinical or early clinical data.
Classification Click here for help
Compound class Antibody
International Nonproprietary Names Click here for help
INN number INN
11873 etesevimab
Synonyms Click here for help
CB-6 | JS-016 | LY-CoV016 | LY3832479
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 1107
Other databases
GtoPdb PubChem SID 434321766
Search PubMed clinical trials etesevimab
Search PubMed titles etesevimab
Search PubMed titles/abstracts etesevimab